Patents by Inventor Kathrin MUEHLHOELZL-ODOERFER

Kathrin MUEHLHOELZL-ODOERFER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa
    Patent number: 11844860
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: December 19, 2023
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo Inacio, Mark Saunders, Bhanvi Mehta, Kathrin Muehlhoelzl-Odoerfer, Isabel Sole Font, Grazia Caivano
  • METHOD FOR PRODUCING A LIPOSOME DISPERSION
    Publication number: 20230285298
    Abstract: A method for producing a liposome dispersion comprising at least one amphiphilic lipid, wherein the method comprises the steps of: providing a first stream (a) comprising an organic solvent, providing a second stream (b) comprising water, wherein at least one of first stream (a) and second stream (b) comprises the at least one amphiphilic lipid, ejecting the first stream (a) and the second stream (b) through pinholes, and frontally colliding the first stream (a) and the second stream (b), whereby the liposome dispersion comprising the at least one amphiphilic lipid is obtained.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 14, 2023
    Inventors: Kathrin MUEHLHOELZL-ODOERFER, Elke HORSTKOTTE
  • METHOD FOR PRODUCING NANOPARTICLES
    Publication number: 20220133638
    Abstract: The present invention describes a method for producing nanoparticles, wherein the nanoparticles contain or consist of hydroxypropyl methylcellulose acetate succinate (HPMCAS), and wherein i) HPMCAS is dissolved in an organic solvent in order to obtain an organic solution and ii) the organic solution is mixed with water to precipitate the nanoparticles in order to obtain precipitated nanoparticles and a mixed liquid phase as well as nanoparticles obtained by that method.
    Type: Application
    Filed: May 18, 2020
    Publication date: May 5, 2022
    Inventors: Elke Horstkotte, Kathrin MÜHLHÖLZL-ODÖRFER, Julian VOGLER
  • A PHARMACEUTICAL FORMULATION FOR INTRADUODENAL ADMINISTRATION COMPRISING MELEVODOPA AND CARBIDOPA
    Publication number: 20210007984
    Abstract: A pharmaceutical formulation for intraduodenal administration comprising melevodopa and carbidopa as active ingredients and one or more excipients. Once dispersed in an aqueous medium, melevodopa is completely dissolved, and carbidopa is present as nanoparticles.
    Type: Application
    Filed: February 21, 2019
    Publication date: January 14, 2021
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Ricardo INACIO, Mark SAUNDERS, Bhanvi MEHTA, Kathrin MUEHLHOELZL-ODOERFER, Isabel Sole FONT, Grazia CAIVANO